We are pleased to announce the successful IPO of Terragen, which commences trading on the ASX on 11 December 2019. $20 million was raised under the IPO to fund the commercialisation of Terragen products across Australia and New Zealand, expand into global markets such as the US and Europe, and invest in R&D.

Terragen is an Australian agricultural biotech company which aims to reduce reliance on chemicals and antibiotics, for the benefit of farmers and the environment. Terragen has developed and commercialised a portfolio of natural biological probiotic products for crops and animals.

We congratulate Terragen on its successful ASX listing and are grateful to have been involved in a “first of its kind” ag-biotech IPO on the ASX.